CLPTClearPoint Neuro, Inc.
12.69USD+1.76%Mkt Cap: 379.97M USDP/E: Last update: 2026-06-01

ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. Th…

Indicators:|

Key Statistics

Company
Market Cap379.97M USD
Enterprise Value407.96M USD
Revenue (TTM)40.61M USD
Gross Profit22.69M USD
Net Income (TTM)-25.54M USD
Revenue/Share1.412 USD
Last Price12.69 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees172
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-13.48
PEG0.61
EV/EBITDA-17.28
EV/Revenue10.04
P/S9.36
P/B20.18
EPS (TTM)-1.00
EPS (Forward)-0.94
52W Range
8.27020% of range30.10
52W High30.10 USD
52W Low8.270 USD
Profitability
Gross Margin61.38%
Oper. Margin-69.90%
EBITDA Margin-58.12%
Profit Margin-69.08%
ROE-91.15%
ROA-26.13%
Growth
Revenue Growth42.90%
Earnings Growth
Cash Flow & Leverage
Operating CF-23.93M USD
CapEx (TTM)522.00K USD
FCF Margin-28.64%
FCF Yield-3.06%
Net Debt28.00M USD
Net Debt/EBITDA-1.19
Balance Sheet
Debt/Equity2.08
Current Ratio5.79
Quick Ratio4.75
Book Value/Sh0.6280 USD
Cash/Share1.187 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay DateJul 27, 2016
Splits
Last Split1:40
Split DateJul 27, 2016
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)22.00 USD
Target Range16.00 USD30.00 USD
# Analysts3
Ownership
Shares Out.29.99M
Float26.27M
Insiders8.46%
Institutions50.66%
Short Interest
Short Ratio8.6d
Short % Float15.49%
Short % Out.14.97%
Shares Short4.49M
Short (prev mo.)4.65M
Technical
SMA 5010.64 (+19.3%)
SMA 20014.13 (-10.2%)
Beta1.29
S&P 52W Chg27.94%
Avg Vol (30d)530.50K
Avg Vol (10d)563.42K
Technical Indicators
RSI (14)58.9
MACD0.2462
MACD Signal0.2500
MACD Hist.-0.0038
BB Upper12.93 USD
BB Middle11.77 USD
BB Lower10.61 USD
BB Width19.66%
ATR (14)0.8727 USD
Vol Ratio (20d)2.40x